Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03795116 · ClinicalTrials.gov registry record · Phase 2
Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
A Phase 2 study, sponsored by State University of New York - Downstate Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT03795116 is a Phase 2 study that has completed, run by State University of New York - Downstate Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT03795116, a Phase 2 study, has completed, sponsored by State University of New York - Downstate Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
Skin scarring (fibrosis) is a common complication in the wound healing process and remains a therapeutic challenge. Scar formation often occurs following injury to the skin such as surgery, trauma, and burns. The goal of this study is to evaluate the safety and efficacy of visible red light as a modality to reduce skin scarring after mini-facelift surgery. Based on laboratory data, light emitting diode-red light (LED-RL) phototherapy may lessen post-surgical skin fibrosis clinically.
Interventions
- DEVICE LED-RL phototherapy
- DEVICE Mock irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2020-10-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03795116
The ClinicalTrials.gov registry entry for NCT03795116 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Downstate Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LED-RL phototherapy is the first listed.
NCT03795116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03795116 about?
NCT03795116 is a clinical study titled "Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention". Skin scarring (fibrosis) is a common complication in the wound healing process and remains a therapeutic challenge. Scar formation often occurs following injury to the skin such as surgery, trauma, and burns. The goal of this study is to evaluate the safety and efficacy of visible red light as a mod...
What is the current status of trial NCT03795116?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2019-03-18. Estimated completion is 2020-10-26.
What interventions are being tested in trial NCT03795116?
The interventions under investigation include: LED-RL phototherapy (DEVICE), Mock irradiation (DEVICE).
Who is sponsoring clinical trial NCT03795116?
This trial is sponsored by State University of New York - Downstate Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.